Literature DB >> 17657524

Pathological significance of intracytoplasmic connexin proteins: implication in tumor progression.

Yasufumi Omori1, Qingchang Li, Yuji Nishikawa, Toshiaki Yoshioka, Masayuki Yoshida, Takuya Nishimura, Katsuhiko Enomoto.   

Abstract

A considerable amount of evidence has established that gap junctional intercellular communication (GJIC) suppresses tumor development by halting the stage of tumor promotion. Consistently, GJIC is downregulated in tumors. The downregulation of GJIC is caused by not only the reduced expression level of connexin proteins but also their aberrant cytoplasmic localization. Although it has long been thought that cytoplasmic localization of connexin proteins is merely one of the mechanisms of the downregulation of GJIC, careful studies with human tumor samples have indicated that the expression level of intracytoplasmic connexin proteins correlates well with the grade of malignancy and the progression stage of tumors. Hypothesizing that intracytoplasmic connexin proteins should have their proper functions and that their increase should facilitate tumor progression such as cell migration, invasion and metastasis, we examined the effects of overexpressed connexin32 (Cx32) protein on the phenotype of human HuH7 hepatoma cells, which express a basal level of endogenous Cx32 only in cytoplasm. The cells were retrovirally transduced with the Tet-off Cx32 construct so that withdrawal of doxycycline from the culture medium could induce overexpression of Cx32 protein in cytoplasm. Even when overexpressed, Cx32 protein was retained in cytoplasm, i.e., Golgi apparatuses, and did not induce GJIC. However, overexpression of Cx32 protein in cytoplasm enhanced both the motility and the invasiveness of HuH7 cells and induced metastasis when the cells were xenografted into SCID mice. Taken together, cytoplasmic accumulation of connexin proteins may exert effects favorable for tumor progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657524     DOI: 10.1007/s00232-007-9048-6

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  31 in total

1.  Targeted gap junction protein constructs reveal connexin-specific differences in oligomerization.

Authors:  Jayasri Das Sarma; Fushan Wang; Michael Koval
Journal:  J Biol Chem       Date:  2002-04-02       Impact factor: 5.157

Review 2.  Regulation of connexin biosynthesis, assembly, gap junction formation, and removal.

Authors:  Dominique Segretain; Matthias M Falk
Journal:  Biochim Biophys Acta       Date:  2004-03-23

Review 3.  Role of connexin genes in growth control.

Authors:  H Yamasaki; C C Naus
Journal:  Carcinogenesis       Date:  1996-06       Impact factor: 4.944

Review 4.  The role of human adult stem cells and cell-cell communication in cancer chemoprevention and chemotherapy strategies.

Authors:  James E Trosko; Chia-Cheng Chang; Brad L Upham; Mei-Hui Tai
Journal:  Mutat Res       Date:  2005-08-05       Impact factor: 2.433

5.  Cytoplasmic accumulation of connexin32 protein enhances motility and metastatic ability of human hepatoma cells in vitro and in vivo.

Authors:  Qingchang Li; Yasufumi Omori; Yuji Nishikawa; Toshiaki Yoshioka; Youhei Yamamoto; Katsuhiko Enomoto
Journal:  Int J Cancer       Date:  2007-08-01       Impact factor: 7.396

6.  Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis.

Authors:  Akihiko Ito; Yu-Ichiro Koma; Kazuya Uchino; Tomoyo Okada; Chiho Ohbayashi; Noriaki Tsubota; Morihito Okada
Journal:  Cancer Lett       Date:  2006-03-28       Impact factor: 8.679

7.  Suppression of human prostate cancer cell growth by forced expression of connexin genes.

Authors:  P P Mehta; C Perez-Stable; M Nadji; M Mian; K Asotra; B A Roos
Journal:  Dev Genet       Date:  1999

8.  Role of connexin (gap junction) genes in cell growth control: approach with site-directed mutagenesis and dominant-negative effects.

Authors:  Y Omori; A Duflot-Dancer; M Mesnil; H Yamasaki
Journal:  Toxicol Lett       Date:  1998-08       Impact factor: 4.372

9.  Connexin26-mediated gap junctional communication reverses the malignant phenotype of MCF-7 breast cancer cells.

Authors:  Megumi Momiyama; Yasufumi Omori; Yasuko Ishizaki; Yuji Nishikawa; Takuo Tokairin; Jun-ichi Ogawa; Katsuhiko Enomoto
Journal:  Cancer Sci       Date:  2003-06       Impact factor: 6.716

Review 10.  Downregulation of gap junctions in cancer cells.

Authors:  Edward Leithe; Solveig Sirnes; Yasufumi Omori; Edgar Rivedal
Journal:  Crit Rev Oncog       Date:  2006-12
View more
  12 in total

Review 1.  Physiological and physiopathological aspects of connexins and communicating gap junctions in spermatogenesis.

Authors:  Georges Pointis; Jérome Gilleron; Diane Carette; Dominique Segretain
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

2.  Gene expression profiling studies in regenerating nerves in a mouse model for CMT1X: uninjured Cx32-knockout peripheral nerves display expression profile of injured wild type nerves.

Authors:  Mona Freidin; Samantha Asche-Godin; Charles K Abrams
Journal:  Exp Neurol       Date:  2014-10-23       Impact factor: 5.330

3.  Cytoplasmic localization of connexin 26 suppresses transition of β-catenin into the nucleus in intestinal- and mix-type gastric cancer.

Authors:  Nobuhiro Nakazawa; Makoto Sohda; Takehiko Yokobori; Navchaa Gombodorj; Akihiko Sano; Makoto Sakai; Tetsunari Oyama; Hiroyuki Kuwano; Ken Shirabe; Hiroshi Saeki
Journal:  Ann Gastroenterol Surg       Date:  2022-02-20

4.  Connexin 32 increases the proliferative response of Schwann cells to neuregulin-1 (Nrg1).

Authors:  Mona Freidin; Samantha Asche; Thaddeus A Bargiello; Michael V L Bennett; Charles K Abrams
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

Review 5.  Connexin 43 a check-point component of cell proliferation implicated in a wide range of human testis diseases.

Authors:  Daniel Chevallier; Diane Carette; Dominique Segretain; Jérome Gilleron; Georges Pointis
Journal:  Cell Mol Life Sci       Date:  2012-08-24       Impact factor: 9.261

Review 6.  Connexin43 phosphorylation: structural changes and biological effects.

Authors:  Joell L Solan; Paul D Lampe
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

7.  Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium.

Authors:  M Khair Elzarrad; Abu Haroon; Klaus Willecke; Radoslaw Dobrowolski; Mark N Gillespie; Abu-Bakr Al-Mehdi
Journal:  BMC Med       Date:  2008-07-22       Impact factor: 8.775

8.  The liver connexin32 interactome is a novel plasma membrane-mitochondrial signaling nexus.

Authors:  Stephanie L Fowler; Mark Akins; Hu Zhou; Daniel Figeys; Steffany A L Bennett
Journal:  J Proteome Res       Date:  2013-04-26       Impact factor: 4.466

9.  Connexin32 inhibits gastric carcinogenesis through cell cycle arrest and altered expression of p21Cip1 and p27Kip1.

Authors:  Hyang Jee; Su-Hyung Lee; Jun-Won Park; Bo-Ram Lee; Ki-Taek Nam; Dae-Yong Kim
Journal:  BMB Rep       Date:  2013-01       Impact factor: 4.778

Review 10.  Connexin and pannexin channels in cancer.

Authors:  Jean X Jiang; Silvia Penuela
Journal:  BMC Cell Biol       Date:  2016-05-24       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.